Johnson & Johnson (JNJ)
151.18
+6.59
(+4.56%)
USD |
NYSE |
May 01, 16:00
151.61
+0.43
(+0.28%)
After-Hours: 20:00
Johnson & Johnson Research and Development Expense (TTM): 15.30B for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 15.30B |
December 31, 2023 | 15.21B |
September 30, 2023 | 14.44B |
June 30, 2023 | 14.48B |
March 31, 2023 | 14.35B |
December 31, 2022 | 14.97B |
September 30, 2022 | 15.54B |
June 30, 2022 | 15.48B |
March 31, 2022 | 15.17B |
December 31, 2021 | 14.28B |
September 30, 2021 | 14.21B |
June 30, 2021 | 13.62B |
March 31, 2021 | 12.94B |
December 31, 2020 | 12.34B |
September 30, 2020 | 11.36B |
June 30, 2020 | 11.12B |
March 31, 2020 | 11.08B |
December 31, 2019 | 11.36B |
September 30, 2019 | 11.35B |
June 30, 2019 | 11.26B |
March 31, 2019 | 11.23B |
December 31, 2018 | 10.78B |
September 30, 2018 | 11.19B |
June 30, 2018 | 11.27B |
March 31, 2018 | 10.93B |
Date | Value |
---|---|
December 31, 2017 | 10.59B |
September 30, 2017 | 9.639B |
June 30, 2017 | 9.232B |
March 31, 2017 | 9.20B |
December 31, 2016 | 9.143B |
September 30, 2016 | 9.319B |
June 30, 2016 | 9.295B |
March 31, 2016 | 9.16B |
December 31, 2015 | 9.046B |
September 30, 2015 | 8.817B |
June 30, 2015 | 8.686B |
March 31, 2015 | 8.562B |
December 31, 2014 | 8.494B |
September 30, 2014 | 8.27B |
June 30, 2014 | 8.289B |
March 31, 2014 | 8.23B |
December 31, 2013 | 8.183B |
September 30, 2013 | 8.103B |
June 30, 2013 | 7.984B |
March 31, 2013 | 7.804B |
December 31, 2012 | 7.665B |
September 30, 2012 | 7.489B |
June 30, 2012 | 7.339B |
March 31, 2012 | 7.455B |
December 31, 2011 | 7.548B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
11.08B
Minimum
Mar 2020
15.54B
Maximum
Sep 2022
13.49B
Average
14.24B
Median
Research and Development Expense (TTM) Benchmarks
Amgen Inc | 4.784B |
Eli Lilly and Co | 9.851B |
Merck & Co Inc | 30.25B |
Pfizer Inc | 10.68B |
Shockwave Medical Inc | 145.65M |